drugset / Trial / NCT06165250
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical trial is to evaluate the efficacy and safety of co-administrated BR1018B and BR1018C in patients with essential hypertension and primary hypercholesterolemia
Timeline
- Start
- 2024-04-17
- Primary completion
- 2025-11-11
- Completion
- 2025-11-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BR1018A | Unknown | — | — |
| Subject | BR1018A-1 | Unknown | — | — |
| Subject | BR1018B | Unknown | — | — |
| Comparator | BR1018B-1 | Unknown | — | — |
| Subject | BR1018C | Unknown | — | — |
| Comparator | BR1018C-1 | Unknown | — | — |